Thymosin Alpha-1
Zadaxin
Half-life
2 hr
Time to Peak
1 hr
Steady State
~1 days
Dose Range
0.8–3.2 mg
Frequency
Twice weekly
Overview
Naturally occurring thymic peptide approved in over 30 countries for hepatitis B and C treatment and as an immune system modulator. One of the best-characterized therapeutic peptides with extensive clinical data. Used in the peptide community for immune optimization and general wellness. Supplied as lyophilized powder requiring reconstitution.
Mechanism of Action
Modulates T-cell maturation and function, enhances dendritic cell activity, and stimulates innate and adaptive immune responses. Increases MHC class I expression on tumor cells.
Dosing Information
| Route | Dose Range | Half-life | Tmax | Frequency |
|---|---|---|---|---|
| Subcutaneous (SubQ) | 0.8–3.2 mg | 2 hr | 1 hr | Twice weekly, Daily |
Storage & Handling
2-8C — Store lyophilized powder refrigerated. Reconstitute with provided diluent or sterile water.
Used in Regimens
1 regimenData Sources
- FDA Label Zadaxin (Thymosin Alpha-1) Prescribing Information
Related Tools
Track Thymosin Alpha-1 with Doseline
Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.
Join the waitlistDoseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.